TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference call and report its financial results for the first quarter 2026 ended September 30, 2025, on Tuesday, November 11, 2025. Additional details are available under the Investor Relations section of the Company’s website: https://ir.upexi.com/ Event:Upexi First Quarter 2026 Earni ...

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. ("Terra Innovatum" or the “Company”) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors, announced it will release its third quarter fiscal year 2025 financial results before the opening of financial markets on Monday, November 17, 2025. The Company will conduct a conference call and webcast, hosted by Alessandro Petruzzi, Co-Founder & Chief Executive Officer, Guillaume Moyen, Chief Financial Officer, and Giordano Morichi, Ch ...

PRINCETON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company will host a conference call to report financial results for the quarter ended September 30, 2025 and provide a clinical programs update on Thursday, November 13, 2025 at 8:00 am Eastern Time. Conference Call Details Date: November 13, 2025Ti ...

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), a leader in digitalizing auto insurance and auto services, is generating strong returns from its investment in its Anji AI Technology Services Center as it deepens strategic cooperation with XPeng, Tesla, Xiaomi, and other EV partners. To support its customers’ rapid growth and focus on customer lifetime value, SunCar has actively extended its services to cover the entire lifecycle of vehicle ...

SINGAPORE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, is proud to announce its sponsorship of Mining Disrupt 2025, taking place November 11-13, 2025, in Dallas, TX. Mining Disrupt, one of the world’s largest and most recognized Bitcoin mining conferences and expos, returns for its 8th year. The event brings together leaders across Bitcoin mining, blockchain, energy, AI, and data centers for three da ...

Reported three-month complete response rate of 77.8% from the Phase 3 UTOPIA trial of UGN-103, consistent with ENVISION results; FDA agreed to regulatory plan to submit an NDA based on data from the UTOPIA trial ZUSDURI received unique J-Code (J9282) in October 2025, effective January 1, 2026ZUSDURI achieved net product revenue of $1.8 million in Q3 2025; October 2025 preliminary demand revenue estimate of $4.5 million reflecting accelerating growth entering Q4 2025JELMYTO® achieved net product revenue of $ ...

美国神经科学学会年会，2025 年 11 月 15-19 日，美国加利福尼亚州圣地亚哥马萨诸塞州沃尔瑟姆, Nov. 06, 2025 (GLOBE NEWSWIRE) -- 维泰瑞隆是一家处于临床阶段的全球化生物科技公司，致力于探索和开发用于治疗衰老相关疾病的变革性疗法。公司今日宣布，将在 2025 年美国神经科学学会年会展示三篇壁报。该会议将于 2025 年 11 月 15–19 日在圣地亚哥举行。 壁报详情如下： 壁报1：开发高效、过脑RIPK1变构抑制剂用于神经退行性疾病的治疗 （Development of a Highly Potent, Brain Penetrant and Allosteric RIPK1 Inhibitor for the Treatment of Neurodegenerative Diseases）专场：阿尔茨海默症治疗策略：药物方法 （Alzheimer's Disease Therapeutic Strategies: Pharmaceutical Approaches）编号：PSTR157日期/时间：2025 年 11 月 17 日，上午 8 点至中午 12 点（ ...

Exclusive collaboration and license agreement focuses on advancing novel T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of Immuno-STATs®Novel therapeutic approach is designed to enable in vivo expansion and activation of infused T cell receptor engineered T cells (TCR-Ts) to provide durability, tolerability and enhanced clinical benefit while reducing manufacturing complexityCompelling data generated in preclinical models of multiple solid tumors, including pancreati ...

Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the WorldBASKING RIDGE, N.J. , Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced it is the recipient of “Overall BioPharma Solution of the Year” in the fifth annual BioTech Breakthrough Awards program cond ...

MACAU, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco” or the “Company”), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the third quarter of 2025. Total operating revenues for the third quarter of 2025 were US$1.31 billion, representing an increase of approximately 11% from US$1.18 billion for the comparable period in 2024. The increase in total operating revenues was pri ...